Authors:
MATTAR B
CARABASI MH
TILDEN AB
SALZMAN D
MARTIN B
KUNKEL L
VAUGHAN WP
Citation: B. Mattar et al., IMPROVED OUTCOME IN RECIPIENTS OF HLA IDENTICAL T-CELL DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CONTAINING HIGH-DOSES OF STEM-CELLS, Blood, 90(10), 1997, pp. 4421-4421
Authors:
CARABASI MH
TILDEN AB
SHRESTRA K
SALZMAN D
MARTIN B
VAUGHAN WP
KUNKEL L
BUCY RP
Citation: Mh. Carabasi et al., RAPID IMMUNE RECONSTITUTION IN RECIPIENTS OF T-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS FROM ALA IDENTICAL SIBLINGS, Blood, 90(10), 1997, pp. 2415-2415
Authors:
FREYTES CO
VUKELJA S
SALZMAN D
TSAI T
CALLANDER N
GOKMEN E
RODRIGUEZ T
CASTRO J
BOLDT D
ROODMAN GD
HILSENBECK S
ADKINS D
BACHIER C
CRAIG F
CLARE N
WEISNER A
LEMAISTRE CF
Citation: Co. Freytes et al., AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA, Experimental hematology, 24(9), 1996, pp. 629-629
Authors:
SALZMAN D
ADKINS DR
CRAIG F
FREYTES C
LEMAISTRE CF
Citation: D. Salzman et al., MALIGNANCY-ASSOCIATED PULMONARY VENOOCCLUSIVE DISEASE - REPORT OF A CASE FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND REVIEW, Bone marrow transplantation, 18(4), 1996, pp. 755-760
Citation: Rm. Levy et al., PHARMACOLOGICAL MECHANISM OF PATHOLOGICAL HYPERALGESIA IN NEUROPATHICPAIN - THE ROLE OF THE ALPHA(2B)-ADRENERGIC RECEPTOR, Journal of neurosurgery, 84(2), 1996, pp. 840-840
Authors:
CARABASHI MH
TILDEN AB
SHRESTRA K
SALZMAN D
MARTIN B
VAUGHAN WP
LEBKOWSKI JS
BUCY RP
Citation: Mh. Carabashi et al., IMPACT OF CD8 DEPLETED DONOR LEUKOCYTE INFUSIONS ON IMMUNE FUNCTION IN RECIPIENTS OF HLA-IDENTICAL T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTS, Blood, 88(10), 1996, pp. 1831-1831
Authors:
BROUN ER
NICHOLS CR
MANDANAS R
SALZMAN D
TURNS M
HROMAS R
CORNETTA K
EINHORN LH
Citation: Er. Broun et al., DOSE-ESCALATION STUDY OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS WITH RECURRENT AND REFRACTORY GERM-CELL TUMORS, Bone marrow transplantation, 16(3), 1995, pp. 353-358
Authors:
SALZMAN D
CARABASI MA
BRIGGS AD
GEILS GF
VAUGHAN WP
Citation: D. Salzman et al., HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS BLOOD OR MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA (NHL) AND HODGKINS-DISEASE (HD) AT RISK FOR PULMONARY COMPLICATIONS, Blood, 86(10), 1995, pp. 3840-3840
Authors:
TSAI T
SALZMAN D
CLARK G
CASTRO J
CALLANDER N
BOLDT D
ROODMAN GD
SHERIDANLEOS N
WIESNER A
ADKINS D
HARRIS K
RODRIGUEZ T
GOKMEN E
LEMAISTRE CF
FREYTES CO
Citation: T. Tsai et al., AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 86(10), 1995, pp. 3865-3865
Authors:
ADKINS DR
SALZMAN D
BOLDT D
KUHN J
IRVIN R
ROODMAN GD
LYONS R
SMITH L
FREYTES CO
LEMAISTRE CF
Citation: Dr. Adkins et al., PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA, Journal of clinical oncology, 12(9), 1994, pp. 1890-1901
Authors:
CASTRO J
BACHIER C
BOLDT DH
FREYTES C
HARRIS K
ROODMAN D
SALZMAN D
TAMI J
MENEGHETTI C
SHERIDANLEOS N
LEMAISTRE CF
Citation: J. Castro et al., CRYOPRESERVED MATCHED RELATED DONOR MARROW ENGRAFTS PROMPTLY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000093-10000093
Authors:
SALZMAN D
TAMI J
JACKSON C
CASTRO J
BOLDT D
FREYTES C
BERENSON R
LEMAISTRE CF
Citation: D. Salzman et al., CLINICAL REMISSION OF MYASTHENIA-GRAVIS (MG) IN A PATIENT (PT) AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION WITH CD34-CELLS (SC)(STEM), Blood, 84(10), 1994, pp. 10000206-10000206
Authors:
BACHIER C
FREYTES CO
SALZMAN D
CASTRO J
BOLDT D
ROODMAN GD
HARRIS K
CRAIG F
WIESNER A
LEMAISTRE CF
Citation: C. Bachier et al., BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT POOR-RISK HIGH-GRADE NON-HODGKINS-LYMPHOMA (HGNHL), Blood, 84(10), 1994, pp. 10000703-10000703
Authors:
FREYTES CO
BACHIER C
SALZMAN D
VUKELIA S
CASTRO J
BOLDT D
ROODMAN GD
CRAIG F
HARRIS K
TSAI T
SHERIDANLEOS N
HILSENBECK S
TAMI J
BURRELL L
LEMAISTRE CF
Citation: Co. Freytes et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN RESISTANT OR RECURRENT LOW-GRADE LYMPHOMA, Blood, 84(10), 1994, pp. 10000709-10000709
Authors:
ADKINS D
ENCARNACION C
SALZMAN D
BOLDT D
FREYTES C
VONHOFF DD
LEMAISTRE CF
Citation: D. Adkins et al., DURABLE COMPLETE REMISSION IN A PATIENT WITH REFRACTORY MEDIASTINAL NONSEMINOMATOUS GERM-CELL TUMOR AFTER TANDEM HIGH-DOSE CHEMOTHERAPY ANDAUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 12(5), 1993, pp. 541-546
Authors:
ADKINS DR
IRVIN R
KUHN J
BOLDT DH
ROODMAN GD
SALZMAN D
FREYTES C
VONHOFF DD
LEMAISTRE CF
Citation: Dr. Adkins et al., A PHASE-I CLINICAL AND PHARMACOLOGICAL PROFILE OF DACARBAZINE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS, Investigational new drugs, 11(2-3), 1993, pp. 169-179